Scott Baum - Concepedia

Author

Scott Baum

University of Tennessee Health Science Center

Also Known As

S Baum, S. Baum, S.L. Baum, SCOTT L. BAUM, Scott Baum, Scott L. Baum

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Tennessee Health Science Center Campbell Clinic The University of Texas MD Anderson Cancer Center University of Leeds Banner MD Anderson Cancer Center

About

Scott Baum is an author at University of Tennessee Health Science Center specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	441
2	Immunology	2	2	32
3	Health Sciences	1	1	140
4	Public Health	1	1	61
5	Emergency Medicine	1	1	168

Scott Baum

Publications

555

Citations

H-Index

Page 1

	Year	Citations
Silent deep vein thrombosis in immobilized multiple trauma patients Kenneth A. Kudsk, Timothy C. Fabian, Scott Baum, The American Journal of Surgery ThrombosisVenous DiseaseVenous ThrombosisMedicineHematology	1989	168
Lung Cancer Screening, Version 1.2015 Douglas E. Wood, Ella A. Kazerooni, Scott Baum, Journal of the National Comprehensive Cancer Network PathologyOncologyCancer DetectionLung Cancer ScreeningNodule Reporting	2015	140
AAST Organ Injury Scale Martin A. Croce, Timothy C. Fabian, Kenneth A. Kudsk, The Journal of Trauma: Injury, Infection, and Critical Care	1991	69
Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis Ina L.D. Tonkin, Aram S. Hanissian, Thomas F. Boulden, CardioVascular and Interventional Radiology Pulmonary EmbolismInterventional PulmonologyPulmonary FibrosisPulmonary MedicineBronchial Arteriography	1991	61
Arteriovenous fistula after biopsy of renal transplant kidney: diagnosis and treatment Douglas G. Matsell, Deborah P. Jones, Thomas F. Boulden, Pediatric Nephrology HemodialysisUrologyKidney TransplantKidney TransplantationRenal Transplant Kidney	1992	30
Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. George Yaghmour, Manjari Pandey, Catherine G. Ireland, PubMed	2016	29
An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts. Mark R. Middleton, Francesca Aroldi, Joseph J. Sacco, Journal of Clinical Oncology ImmunologyDermatologyImmunotherapyCancer-associated VirusInitial Results	2020	19
Role of genomic instability in immunotherapy with checkpoint inhibitors. George Yaghmour, Manjari Pandey, Catherine G. Ireland, Journal of Clinical Oncology	2016	16
422 An open-label, multicenter, phase 1/2 clinical trial of RP1, an enhanced potency oncolytic HSV, combined with nivolumab: updated results from the skin cancer cohorts Mark R. Middleton, Francesca Aroldi, Joseph J. Sacco, Regular and Young Investigator Award Abstracts Melanoma Phase 2ImmunologyImmunoeditingImmunotherapeuticsDermatology	2020	13
Bronchopleural Fistula Treated with N-Butyl Cyanoacrylate Glue after Ablation Daniel K. Powell, Scott Baum Journal of Vascular and Interventional Radiology N-butyl Cyanoacrylate GlueInterventional PulmonologyThoracic SurgerySurgerySoft Tissue Reconstruction	2018	10

Page 1